Literature DB >> 17713470

The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).

R P Owen1, T E Klein, R B Altman.   

Abstract

The pharmacogenetics and pharmacogenomics knowledge base (PharmGKB, http://www.pharmgkb.org) is a publicly available internet resource dedicated to the integration, annotation, and aggregation of pharmacogenomic knowledge. PharmGKB is a repository for pharmacogenetic and pharmacogenomic data, and curators provide integrated knowledge in terms of gene summaries, pathways, and annotated literature. Although PharmGKB is primarily directed toward catalyzing new research, it also has utility as a source of information for education about pharmacogenomics.

Mesh:

Substances:

Year:  2007        PMID: 17713470     DOI: 10.1038/sj.clpt.6100332

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?

Authors:  Harry Enchin
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

2.  PharmGKB: understanding the effects of individual genetic variants.

Authors:  Katrin Sangkuhl; Dorit S Berlin; Russ B Altman; Teri E Klein
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 3.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

Review 4.  From gene networks to drugs: systems pharmacology approaches for AUD.

Authors:  Laura B Ferguson; R Adron Harris; Roy Dayne Mayfield
Journal:  Psychopharmacology (Berl)       Date:  2018-03-01       Impact factor: 4.530

5.  Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.

Authors:  Katrina M Romagnoli; Richard D Boyce; Philip E Empey; Solomon Adams; Harry Hochheiser
Journal:  Int J Med Inform       Date:  2015-11-30       Impact factor: 4.046

6.  Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma.

Authors:  Xin Xiao; Wei Wang; Haoqiang Zhang; Peng Gao; Bo Fan; Chen Huang; Jun Fu; Guojing Chen; Lei Shi; Haodong Zhu; Xiangdong Li; Jing Li; Hongbin Fan; Zhigang Wu; Zheng Guo; Yongcheng Hu; Sujia Wu; Xiuchun Yu; Cheng Xu; Zhen Wang
Journal:  Tumour Biol       Date:  2014-11-28

7.  Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population.

Authors:  Yujing Cheng; Qi Li; Xin Yang; Heng Ding; Wanlu Chen; Run Dai; Chan Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.